Who Paid My Doc
Kacper Pierwola
Brain Injury Medicine Lancaster, PA Medical Doctor
NPI 1831542885 CMS profile 5702907
675 Good Dr, Lancaster, PA 17601
General payments
$145
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Kacper Pierwola of Lancaster, PA is reported in the CMS Open Payments database as having received $145 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $145 | 6 |
Beside peers
- Kacper Pierwola
- Brain Injury Medicine median
- Middle half of Brain Injury Medicine
- National median
In program year 2025, general payments to Kacper Pierwola were reported at $145. Among 31 Brain Injury Medicine profiles paid that year, the median was $165 and the middle half received between $36 and $391.
Show as a table
| Year | Kacper Pierwola | Brain Injury Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $110 | $51–$240 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $61 | $22–$274 | $132 |
| 2022 | $0 | $79 | $26–$281 | $149 |
| 2023 | $0 | $125 | $49–$275 | $160 |
| 2024 | $0 | $139 | $75–$423 | $164 |
| 2025 | $145 | $165 | $36–$391 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
142
Drug cost
$1,289
Branded share of claims
9.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Baclofen | Generic | 30 | $371 | |
| Gabapentin | Generic | 37 | $313 | |
| Tizanidine Hcl | Generic | 11 | $292 | |
| Venlafaxine Hcl Er Venlafaxine Hcl | Brand | 13 | $179 | |
| Trazodone Hcl | Generic | 34 | $87 | |
| Oxycodone Hcl | Generic | 17 | $47 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 28 billing codesPaid by Medicare
$96,195
Medicare patients
160
Services billed
2,778
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 68% | |
| Chronic kidney disease | 63% | |
| Depression | 53% | |
| Diabetes | 48% | |
| Heart failure | 43% | |
| Atrial fibrillation | 39% | |
| Ischemic heart disease | 38% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Brain Injury Medicine in Pennsylvania
Related records
Brain Injury Medicine in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Brain Injury Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.